Tagamet Syrup is indicated for:
The treatment of duodenal and benign gastric ulceration, including that associated with non-steroidal anti-inflammatory agents, recurrent and stomal ulceration, oesophageal reflux disease and other conditions where reduction of gastric acid by Cimetidine has been shown to be beneficial: persistent dyspeptic symptoms with or without ulceration, particularly meal-related upper abdominal pain, including such symptoms associated with non-steroidal anti-inflammatory agents; the prophylaxis of gastrointestinal haemorrhage from stress ulceration in critically ill patients; before general anaesthesia in patients thought to be at risk of acid aspiration (Mendelson’s) syndrome, particularly obstetric patients during labour; to reduce malabsorption and fluid loss in the short bowel syndrome; and in pancreatic insufficiency to reduce degradation of enzyme supplements. Cimetidine is also recommended in the management of the Zollinger-Ellison syndrome.
Summary of Product Characteristics
Read this summary of product characteristics for further information about Tagamet Syrup. Click below to navigate to the EMC.
Patient Information Leaflet
Read this patient information leaflet about Tagamet Syrup, what it’s used for and possible side effects. Click below to navigate to the EMC.
Tagamet Syrup (Cimetidine)
|Click here for Audio Version
|Store below 25°C
|Shelf Life (Closed Bottle)
For further product information and pricing please use the form below and a member of the team will be in touch
Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.